🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Actuate Therapeutics, Inc.

ACTU Healthcare
$1.8 +$0.3 (19.67%)
Market Cap: $42.95 M
Gurus Holding
1
Popularity Rank
#4821
% of Shares Held
0.11%
Net Activity (Q1 2026)
+$74,278

Guru Ownership Trend

Guru Analysis for Actuate Therapeutics, Inc. (ACTU)

Actuate Therapeutics, Inc. (ACTU), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $48,660.66.

Top institutional holders include Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $74,278 net inflow during the quarter.

Recent activity highlights Cliff Asness who opened a new position.

Key Holders

Top 5 by Value

$74,278

Top 5 by Conviction

0.00%

Recent Activity Breakdown (Q1 2026)

+$74,278
Total Buy Value
New Buys 1
Additions 0
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
0
Net Buyers
1

FAQs for Actuate Therapeutics, Inc. (ACTU)

Major holders include Cliff Asness ($74,278). According to the latest reported data, 1 tracked investment managers collectively hold approximately 27,109 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $74,278, with 1 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in ACTU during the most recent reporting period.

Yes, 1 managers opened new positions in ACTU, and 0 increased their existing holdings. The total reported buy value was $74,278.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 27,109 $74,278 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form